It's nice to see the share price trending back up and lack of...

It's nice to see the share price trending back up and lack of sell depth, but feel a bit frustrated with AMO overall. Raised $5.4m in October last year with talk of acquisition for growth, yet only $1.28m went on an acquisition and the rest soaked up on debt and working capital. So not sure if the dilution can be justified by growth? Last indication on this was in the half year result, where the last outlook comment was:

"Whilst it is too early to provide guidance for the full year results, the second half has commenced with results meeting targets. We will keep shareholders updated as the year progresses"

Hmmm, running out of time for that update! Leaves it wide open as to where results could sit against pcp - there's a prime chance they'll still look very cheap, but how long for? Would have to think belt-tightening will impact their market in 2023. Still think the shares are way too "cheap" to sell on a revenue and yield basis, but they're not giving me confidence that they're a company I can trust to "say what they'll do and to do what they say". Makes a huge difference. While I think there's value here to upper 40's, I also think I'd be de-risking long before that without any update.

Any thoughts?